Nachrichten zur West Pharmaceutical Services Inc. Aktie

West Pharmaceutical Services (WST) Tops Q3 Earnings and Revenue Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of +17.37% and +2.43%, respectively, for the quarter ended September 2025. Do…

West Pharmaceutical Services, Inc. (WST) Presents at Bank of America Global Healthcare Conference 2025 Transcript

…

West Pharmaceuticals - Pharmazulieferer profitiert von Nachzieheffekten aus der Pharma- und Biotechbranche!

Geschäftstreiber: Bei West Pharmaceuticals handelt sich um einen Produzenten von Komponenten und Geräten für die Herstellung von Pharmazeutika, Biologika, Impfstoffen…

West Pharmaceutical (WST) Upgraded to Strong Buy: Heres Why

West Pharmaceutical (WST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings…

West Pharmaceutical Services: Low Debt, High Profit, And A Waning Destocking Problem

…

KeyBanc maintains Overweight rating on West Pharmaceutical stock By Investing.com

KeyBanc maintains Overweight rating on West Pharmaceutical stock…

WST Q2 Earnings Preview: Will the Stocks Segmental Edge Hold Up?

West Pharmaceutical targets steady Q2 growth as high-value GLP-1 and SmartDose demand drives segment momentum.…

Deadline Alert: West Pharmaceutical Services, Inc. (WST) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

LOS ANGELES, June 30, 2025 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP reminds investors of the upcoming…

WST Stock Builds on GLP-1 Growth, Annex 1 and Margins in Focus

West Pharmaceutical Services rides on GLP-1 demand and Annex 1 expansion, but margins face pressure from pricing and tariff headwinds.…

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Compass Diversified, Digimarc, Elevance, and West Pharmaceutical and Encourages Investors to Contact the Firm

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…

WST IMPORTANT DEADLINE: ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 15, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Wall Street Analysts Believe West Pharmaceutical (WST) Could Rally 26.92%: Heres is How to Trade

The mean of analysts price targets for West Pharmaceutical (WST) points to a 26.9% upside in the stock. While this…

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, June 08, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

WST INVESTOR ALERT: Kirby McInerney LLP Notifies West Pharmaceutical Services, Inc. Investors of Upcoming Lead Plaintiff Deadline in Class Action Lawsuit

NEW YORK, June 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of…

The Gross Law Firm Reminds West Pharmaceutical Services, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 7, 2025 – WST

NEW YORK, May 21, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders…

[Latest] Global Pharmaceutical Contract Packaging Market Size/Share Worth USD 34.80 Billion by 2034 at a 7.34% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT)

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global…

West Pharmaceutical (WST) Upgraded to Buy: Heres What You Should Know

West Pharmaceutical (WST) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to…

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in West Pharmaceutical Services, Inc. of Class Action Lawsuit and Upcoming Deadlines - WST

NEW YORK, May 18, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been…

ROSEN, NATIONAL TRIAL COUNSEL, Encourages West Pharmaceutical Services, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WST

NEW YORK, May 17, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…

Earnings Preview: West Pharmaceutical Services (WST) Q1 Earnings Expected to Decline

West Pharmaceutical (WST) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…

West Pharmaceutical Services Aktie: Mehr als vorgesehen?

Analyse der aktuellen Börsenperformance von West Pharmaceutical Services mit strategischer Neuausrichtung nach Beendigung wichtiger Kundenpartnerschaften. Die Aktie von West Pharmaceutical…

West Pharmaceutical Services (WST) Surpasses Q4 Earnings and Revenue Estimates

West Pharmaceutical (WST) delivered earnings and revenue surprises of 4% and 1.25%, respectively, for the quarter ended December 2024. Do…

Will Segmental Performance Drive West Pharmaceuticals Q4 Earnings?

West Pharmaceutical Services eyes fourth-quarter growth amid pharma stabilization, biologics rebound & contract manufacturing gains. Can WST sustain its momentum?…

West Pharmaceutical Services started at buy by Citi

…

West Pharmaceutical Services announces share repurchase program

…

Whats in Store for West Pharmaceutical in Q3 Earnings?

WSTs third-quarter 2024 results are likely to reflect weakness in its Proprietary Products business. Unfavorable currency movements might have hurt…

West Pharmaceutical Services Aktie: Kursanstieg trotz Monatsrückgang

Der Aktienkurs von West Pharmaceutical Services zeigt eine gemischte Performance. Am 19. Oktober 2024 verzeichnete die Aktie einen Anstieg von…

West Pharmaceutical Services Aktie: Quartalsbericht steht bevor

Die West Pharmaceutical Services Aktie zeigt sich kurz vor der Veröffentlichung des nächsten Quartalsberichts am 24. Oktober 2024 relativ stabil.…

West Pharmaceutical Services Aktie: Stabiler Kurs trotz Marktschwankungen

Die West Pharmaceutical Services Aktie zeigt sich in einem volatilen Marktumfeld relativ stabil. Zum Handelsschluss am 22. September 2024 notierte…

Whats in Store for West Pharmaceutical (WST) in Q2 Earnings?

West Pharmaceuticals (WST) second-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements…

Global Closed System Transfer Devices Market Size To Worth USD 3.35 Billion By 2033 l CAGR of 9.93%

The Global Closed System Transfer Devices Market Size was Valued at USD 1.3 Billion in 2023 and the Worldwide Closed…

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…

West Pharmaceutical: Pick And Shovels Of The Injectable Drug Industry

…

West Pharmaceutical Services, Inc. 2024 Q1 - Results - Earnings Call Presentation

…

West Pharmaceutical Services, Inc. (WST) Q1 2024 Earnings Call Transcript

…

West Pharmaceutical (WST) Q1 Earnings Beat, HVP Sales Weak

West Pharmaceuticals (WST) first-quarter results reflect a strong demand for non-COVID-19 products, especially HVP devices.…

Is a Beat Likely for West Pharmaceutical (WST) in Q1 Earnings?

West Pharmaceuticals (WST) first-quarter 2024 results are likely to reflect strength in its Proprietary Products business. However, unfavorable currency movements…

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…

Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now

West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.…

Kurs von West Pharmaceutical Services steigt etwas (341,5054 €)

An der US-amerikanischen Börse liegt die West Pharmaceutical Services-Aktie aktuell im Plus. Zuletzt zahlten Investoren für das Wertpapier 372,90 US-Dollar.…

West Pharmaceutical Services-Aktie: Kurs fällt ab (311,4030 €)

Im Minus liegt zur Stunde die Aktie von West Pharmaceutical Services . Zuletzt zahlten Investoren für die Aktie 339,94 US-Dollar.…

dpa-AFX ProFeed